Resources We partner with pharma to advance neuroscience research All ResourcesPress ReleasesIn the newsPublications AxoSim Speaks at 2024 ADC Toxicity Summit July 25, 2024 | Publications Read More → MPS Features Three AxoSim Scientists at 2024 World Summit June 25, 2024 | Publications Read More → AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption June 11, 2024 | Press Releases Read More → Comparative assessment of Ca2+ oscillations in 2- and 3-dimensional hiPSC derived and isolated cortical neuronal networks May 24, 2024 | Publications Read More → AxoSim Posters Featured at SOT 2024 Annual Meeting March 26, 2024 | Publications Read More → AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors February 28, 2024 | Press Releases Read More → Fierce Biotech: Organoids touted as future of brain disorder R&D as AxoSim scoops up tech from Vyant subsidiary December 15, 2023 | In the news Read More → Latest Acquisition Lands AxoSim in the News November 28, 2023 | In the news Read More → AXOSIM EXTENDS LEADERSHIP IN HUMAN ORGANOIDS FOR NEUROLOGICAL DRUG DISCOVERY WITH ACQUISITION OF STEMONIX MICROBRAIN™ TECHNOLOGY October 31, 2023 | Press Releases Read More → 1 2 3 4 Next »
